We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+8.53%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$9.21B
AUM Growth
-$376M
Cap. Flow
-$1.01B
Cap. Flow %
-10.92%
Top 10 Hldgs %
39.08%
Holding
194
New
61
Increased
26
Reduced
38
Closed
60

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$295M
2
MGM icon
MGM Resorts International
MGM
+$236M
3
CCI icon
Crown Castle
CCI
+$185M
4
BABA icon
Alibaba
BABA
+$165M
5
CTRA
Coterra Energy
CTRA
+$161M

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$395M
2
OVV icon
Ovintiv
OVV
+$154M
3
VIAB
Viacom Inc. Class B
VIAB
+$150M
4
FANG icon
Diamondback Energy
FANG
+$120M
5
PNC icon
PNC Financial Services
PNC
+$112M

Sector Composition

Rank Sector Weight
1 Financials 15.88%
2 Communication Services 15.8%
3 Energy 11.19%
4 Consumer Discretionary 10.16%
5 Healthcare 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVXS
51
DELISTED
AveXis, Inc. Common Stock
AVXS
$44.8M 0.49%
544,667
+295,600
+119% +$22.2M
BIIB icon
52
Biogen
BIIB
$30.7B
$42.3M 0.46%
155,930
-177,570
-53% -$47M
SUPV
53
Grupo Supervielle
SUPV
$845M
$42.2M 0.46%
2,334,457
-312,904
-12% -$5.37M
MDCO
54
DELISTED
Medicines Co
MDCO
$42M 0.46%
1,103,966
+8,866
+0.8% +$395K
XYL icon
55
Xylem
XYL
$28.5B
$34.1M 0.37%
+615,700
New +$32.1M
FNF icon
56
Fidelity National Financial
FNF
$14.6B
$34M 0.37%
+1,091,823
New +$31.5M
NKTR icon
57
Nektar Therapeutics
NKTR
$2.38B
$33.8M 0.37%
115,400
+85,167
+282% +$24.6M
SFM icon
58
Sprouts Farmers Market
SFM
$7.45B
$33M 0.36%
+1,453,659
New +$33.7M
CFG icon
59
Citizens Financial Group
CFG
$30.6B
$31M 0.34%
869,154
-1,502,746
-63% -$53.3M
DKS icon
60
Dick's Sporting Goods
DKS
$18.7B
$28.2M 0.31%
707,200
+66,500
+10% +$3M
PCRX icon
61
Pacira BioSciences
PCRX
$1.04B
$27.3M 0.3%
571,500
-634,400
-53% -$29.4M
FMC icon
62
FMC
FMC
$1.3B
$25.1M 0.27%
+396,401
New +$25.5M
ACRS icon
63
Aclaris Therapeutics
ACRS
$726M
$22.7M 0.25%
838,800
-132,300
-14% -$3.6M
IRTC icon
64
iRhythm Holdings
IRTC
$4.05B
$22.2M 0.24%
522,900
+119,200
+30% +$4.34M
SRPT icon
65
Sarepta Therapeutics
SRPT
$1.66B
$21.3M 0.23%
631,922
-6,978
-1% -$227K
OIBR.C
66
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$21.2M 0.23%
3,516,580
-1,698,623
-33% -$10.5M
HYG icon
67
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$18.8M 0.2%
+212,500
New +$18.7M
SCHW
68
Charles Schwab
SCHW
$184B
$18M 0.2%
+419,500
New +$16.8M
YPF icon
69
YPF
YPF
$19.8B
$16.6M 0.18%
757,013
– –
AAP icon
70
Advance Auto Parts
AAP
$3.54B
$16.4M 0.18%
+140,300
New +$19.3M
PRTA icon
71
Prothena Corp
PRTA
$452M
$14.7M 0.16%
+272,500
New +$14.5M
DVAX
72
DELISTED
Dynavax Technologies
DVAX
$13.5M 0.15%
+1,400,000
New +$9.09M
CDK
73
DELISTED
CDK Global, Inc.
CDK
$12.8M 0.14%
+206,400
New +$12.9M
CYH icon
74
Community Health Systems
CYH
$385M
$12.6M 0.14%
1,262,600
-607,400
-32% -$5.55M
VAR
75
DELISTED
Varian Medical Systems, Inc.
VAR
$12.5M 0.14%
+121,200
New +$11.7M
1 2
3
4 5

Similar funds

CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
MT
Midwest Trust Overland Park, Kansas $8.02B AUM 23.54% 1-Year Est. Return

PointState Capital's Q2 2017 Portfolio in Review

As of Q2 2017, PointState Capital held 194 positions worth $9.21B, down 3.9% from $9.59B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

PointState Capital withdrew a net $1.01B in Q2 2017, closing 60 positions and reducing 38 holdings. Its most notable exit was Ovintiv, an estimated $154M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 11% a quarter earlier, followed by Communication Services and Energy.

Against the trend, PointState Capital opened a new position in Citigroup worth $321M.

  • PointState Capital's largest Q2 2017 buy was Citigroup: 4,804,460 shares worth $321M.
  • PointState Capital added most to Alibaba in Q2 2017, an estimated $165M increase.
  • PointState Capital's biggest Q2 2017 reduction was DuPont de Nemours, cutting an estimated $395M.
  • PointState Capital fully exited Ovintiv in Q2 2017, selling an estimated $154M.
  • PointState Capital's ten largest holdings make up 39% of its $9.21B portfolio in Q2 2017.
  • PointState Capital opened 61 new positions and closed 60 in Q2 2017.
  • PointState Capital's portfolio value fell 3.9% quarter-over-quarter to $9.21B.

Based on PointState Capital's 13F filing for Q2 2017, filed 14 Aug 2017.